Form 4: ClearPoint Neuro Director Linda M. Liau Settles Restricted Stock Units

Director Linda M. Liau settled 21,093 restricted stock units into common stock of ClearPoint Neuro, Inc. on May 16, 2025.

Summary

• On May 16, 2025, Linda M. Liau, a director of ClearPoint Neuro, Inc., settled 21,093 restricted stock units (RSUs) into shares of common stock.
• The settlement occurred because the RSUs vested on the earlier of the first anniversary of the grant date or the day immediately preceding the company's 2025 annual meeting of stockholders.
• The original grant date for these RSUs was May 16, 2024.
• Following the transaction, Liau directly owns 52,384 shares of ClearPoint Neuro common stock.
• The transaction was executed under a power of attorney held by Danilo D'Alessandro.

Sentiment

Score: 5

Explanation: This is a neutral event, reflecting a standard vesting and settlement of restricted stock units. It doesn't inherently indicate positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions and is a standard part of regulatory compliance for publicly traded companies. It provides transparency to investors regarding the actions of company insiders.

Stakeholder Impact

• The transaction increases the number of outstanding shares, which could have a minor dilutive effect on existing shareholders.

Key Dates

Keywords

ClearPoint Neuro, Linda M. Liau, restricted stock units, Form 4, securities, director, CLPT, common stock, settlement, vesting